ReviewSensors (Basel, Switzerland)2025
Near-Infrared-II Fluorescence Imaging of Tumors with Organic Small-Molecule Fluorophores.
Review in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Recent Advances in Organofluoroprobes for Brain Imaging: Progress, Challenges, and Future Directions.ACS pharmacology & translational science · 2026Review
- Solvatochromic Study of 2‑(ACS omega · 2026Article
- Near-Infrared and Shortwave Infrared Building Blocks for Activity-Based Sensors in Animals.Bioconjugate chemistry · 2026Review
- Comparison of Fluorescent Probes for IDH-Wildtype Glioblastoma, Metastatic Brain Tumors, and PCNSL: A Biomechanical Perspective.International journal of molecular sciences · 2026Review
- Advances in NIR-II Fluorescence Laparoscopy for Precision Diagnosis and Theranostics of Urological Oncology.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past decade, near-infrared-II (NIR-II, 1000-1700 nm) fluorescence imaging has become a focal point in tumor imaging due to its advantages of low light scattering, weak biological autofluorescence, extraordinary penetration depth, high signal-to-background ratio, and micron-level high resolution. To date, a large number of NIR-II materials have been developed for tumor imaging. Among them, NIR-II organic small-molecule fluorophores have emerged as research hotspots owing to their distinctive advantages, such as superior optical properties, excellent controllability, favorable biocompatibility, and tunable pharmacokinetics. In this review, we summarize the latest progress in lNIR-II fluorescent probes based on organic small-molecule fluorophores for tumor imaging, focusing on their structural features, design principles of NIR-II fluorescent probes, and applications in tumor imaging. Finally, we will discuss the challenges, future prospects, and development directions of organic small-molecule fluorophores for NIR-II fluorescence imaging of tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.